Groesbeck Parham to Adult
This is a "connection" page, showing publications Groesbeck Parham has written about Adult.
Connection Strength
2.609
-
A portable thermal ablation device for cervical cancer prevention in a screen-and-treat setting: a randomized, noninferiority trial. Nat Med. 2024 Sep; 30(9):2596-2604.
Score: 0.166
-
Internal validation of Automated Visual Evaluation (AVE) on smartphone images for cervical cancer screening in a prospective study in Zambia. Cancer Med. 2024 Jun; 13(11):e7355.
Score: 0.165
-
Three-year survival of breast cancer patients attending a one-stop breast care clinic nested within a primary care health facility in sub-Saharan Africa-Zambia. Int J Cancer. 2024 Jul 15; 155(2):261-269.
Score: 0.163
-
The Ability to Look: Management of Breast Disease in the Democratic Republic of the Congo Using Smart Ultrasound Technology. J Am Coll Surg. 2021 04; 232(4):636-640.
Score: 0.130
-
Partnering with traditional Chiefs to expand access to cervical cancer prevention services in rural Zambia. Int J Gynaecol Obstet. 2019 Mar; 144(3):297-301.
Score: 0.114
-
Demonstration of an algorithm to overcome health system-related barriers to timely diagnosis of breast diseases in rural Zambia. PLoS One. 2018; 13(5):e0196985.
Score: 0.109
-
Leverage of an Existing Cervical Cancer Prevention Service Platform to Initiate Breast Cancer Control Services in Zambia: Experiences and Early Outcomes. J Glob Oncol. 2018 09; 4:1-8.
Score: 0.104
-
Clinical Performance Validation of 4 Point-of-Care Cervical Cancer Screening Tests in HIV-Infected Women in Zambia. J Low Genit Tract Dis. 2016 Jul; 20(3):218-23.
Score: 0.096
-
Implementation and Operational Research: Age Distribution and Determinants of Invasive Cervical Cancer in a "Screen-and-Treat" Program Integrated With HIV/AIDS Care in Zambia. J Acquir Immune Defic Syndr. 2015 Sep 01; 70(1):e20-6.
Score: 0.090
-
Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia. PLoS One. 2015; 10(4):e0122169.
Score: 0.088
-
Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in Zambia. PLoS One. 2013; 8(9):e74607.
Score: 0.079
-
Myths and misconceptions about cervical cancer among Zambian women: rapid assessment by peer educators. Glob Health Promot. 2010 Jun; 17(2 Suppl):47-50.
Score: 0.063
-
Strategies for achieving healthy energy balance among African Americans in the Mississippi Delta. Prev Chronic Dis. 2007 Oct; 4(4):A97.
Score: 0.052
-
Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol. 2006 Dec; 103(3):1017-22.
Score: 0.048
-
Survival deficits in young women with breast cancer in sub-Saharan Africa: the African Breast Cancer-Disparities in Outcomes cohort. J Natl Cancer Inst. 2025 Nov 01; 117(11):2298-2307.
Score: 0.046
-
Breast cancer overall survival, annual risks of death, and survival gap apportionment in sub-Saharan Africa (ABC-DO): 7-year follow-up of a prospective cohort study. Lancet Glob Health. 2025 Oct; 13(10):e1681-e1690.
Score: 0.045
-
Predictors of outcomes for women with cervical carcinoma. Gynecol Oncol. 2005 Nov; 99(2):432-6.
Score: 0.045
-
Economic evaluation of thermal ablation compared to cryotherapy and loop diathermy in a screen-and-treat approach to cervical cancer, Zambia. Bull World Health Organ. 2025 Sep 01; 103(9):530-540.
Score: 0.045
-
Vaginal microbiome composition in women with HIV undergoing treatment of cervical transformation zone in a screen and treat program in Zambia. AIDS. 2025 Jul 15; 39(9):1303-1306.
Score: 0.045
-
Geospatial disparities in survival of patients with breast cancer in sub-Saharan Africa from the African Breast Cancer-Disparities in Outcomes cohort (ABC-DO): a prospective cohort study. Lancet Glob Health. 2024 Jul; 12(7):e1111-e1119.
Score: 0.041
-
Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10. Int J Radiat Oncol Biol Phys. 2002 Dec 01; 54(5):1345-55.
Score: 0.037
-
Treatment guideline concordance, initiation, and abandonment in patients with non-metastatic breast cancer from the African Breast Cancer-Disparities in Outcomes (ABC-DO) cohort in sub-Saharan Africa: a prospective cohort study. Lancet Oncol. 2022 06; 23(6):729-738.
Score: 0.036
-
Self-reported arm and shoulder problems in breast cancer survivors in Sub-Saharan Africa: the African Breast Cancer-Disparities in Outcomes cohort study. Breast Cancer Res. 2021 11 24; 23(1):109.
Score: 0.035
-
Increased levels of interleukin-10 and transforming growth factor-beta in the plasma and ascitic fluid of patients with advanced ovarian cancer. BJOG. 2001 Aug; 108(8):804-8.
Score: 0.034
-
Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer. Gynecol Obstet Invest. 2001; 51(4):254-61.
Score: 0.033
-
Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix. Int J Radiat Oncol Biol Phys. 2000 Nov 01; 48(4):997-1006.
Score: 0.032
-
Few Losses to Follow-up in a Sub-Saharan African Cancer Cohort via Active Mobile Health Follow-up. Am J Epidemiol. 2020 10 01; 189(10):1185-1196.
Score: 0.032
-
Induction of ovarian tumor-specific CD8+ cytotoxic T lymphocytes by acid-eluted peptide-pulsed autologous dendritic cells. Obstet Gynecol. 2000 Sep; 96(3):422-30.
Score: 0.032
-
In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer. Am J Obstet Gynecol. 2000 Sep; 183(3):601-9.
Score: 0.032
-
Breast cancer survival and survival gap apportionment in sub-Saharan Africa (ABC-DO): a prospective cohort study. Lancet Glob Health. 2020 09; 8(9):e1203-e1212.
Score: 0.032
-
Comparison of immediate and deferred colposcopy in a cervical screening program. Obstet Gynecol. 2000 Mar; 95(3):340-4.
Score: 0.031
-
Development, characterization and distribution of adoptively transferred peripheral blood lymphocytes primed by human papillomavirus 18 E7--pulsed autologous dendritic cells in a patient with metastatic adenocarcinoma of the uterine cervix. Eur J Gynaecol Oncol. 2000; 21(1):17-23.
Score: 0.030
-
Thermal ablation versus cryotherapy or loop excision to treat women positive for cervical precancer on visual inspection with acetic acid test: pilot phase of a randomised controlled trial. Lancet Oncol. 2020 01; 21(1):175-184.
Score: 0.030
-
Secretion of vascular endothelial growth factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix. Obstet Gynecol. 1999 Jul; 94(1):78-82.
Score: 0.029
-
Secretion of vascular endothelial growth factor in ovarian cancer. Eur J Gynaecol Oncol. 1999; 20(3):177-81.
Score: 0.028
-
Differences in Cervical Cancer Screening Knowledge and Practices by HIV Status and Geographic Location: Implication for Program Implementation in Zambia. Afr J Reprod Health. 2018 Dec; 22(4):92-101.
Score: 0.028
-
Effectiveness of the Papanicolaou smear and speculoscopy as compared with the Papanicolaou smear alone: a community-based clinical trial. Obstet Gynecol. 1997 Sep; 90(3):421-7.
Score: 0.026
-
The National Cancer Data Base report on malignant epithelial ovarian carcinoma in African-American women. Cancer. 1997 Aug 15; 80(4):816-26.
Score: 0.026
-
African Breast Cancer-Disparities in Outcomes (ABC-DO): protocol of a multicountry mobile health prospective study of breast cancer survival in sub-Saharan Africa. BMJ Open. 2016 08 23; 6(8):e011390.
Score: 0.024
-
The Effect of Cryotherapy on Human Papillomavirus Clearance Among HIV-Positive Women in Lusaka, Zambia. J Low Genit Tract Dis. 2015 Oct; 19(4):301-6.
Score: 0.023
-
The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: a modeling study. BMC Cancer. 2015 Jul 24; 15:541.
Score: 0.022
-
Primary lymphatic dissemination of malignant elements in a mature cystic ovarian teratoma. Gynecol Oncol. 1995 May; 57(2):250-3.
Score: 0.022
-
Preference for human papillomavirus-based cervical cancer screening: results of a choice-based conjoint study in Zambia. J Low Genit Tract Dis. 2015 Apr; 19(2):119-23.
Score: 0.022
-
Metastasis from a stage IB cervical adenocarcinoma in a transposed ovary: a case report and review of the literature. Gynecol Oncol. 1994 Dec; 55(3 Pt 1):469-72.
Score: 0.021
-
Clinical performance of digital cervicography and cytology for cervical cancer screening in HIV-infected women in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2014 Oct 01; 67(2):212-5.
Score: 0.021
-
Significance of a first-time atypical Papanicolaou smear in a young, high-risk African-American and Latino-American population. J Natl Med Assoc. 1994 Apr; 86(4):273-7.
Score: 0.020
-
Recommendations for cervical cancer prevention in sub-saharan Africa. Vaccine. 2013 Dec 29; 31 Suppl 5:F73-4.
Score: 0.020
-
Innovative approaches to promoting cervical health and raising cervical cancer awareness by use of existing cultural structures in resource-limited countries: experiences with traditional marriage counseling in Zambia. Glob Health Promot. 2013 Dec; 20(4 Suppl):57-64.
Score: 0.020
-
Motivations and experiences of women who accessed "see and treat" cervical cancer prevention services in Zambia. J Psychosom Obstet Gynaecol. 2012 Jun; 33(2):91-8.
Score: 0.018
-
Hyperparathyroidism secondary to parathyroid carcinoma in pregnancy. A case report. J Reprod Med. 1987 Feb; 32(2):123-5.
Score: 0.012
-
A community-driven action plan to eliminate breast and cervical cancer disparity: successes and limitations. J Cancer Educ. 2006; 21(1 Suppl):S91-100.
Score: 0.012
-
Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study. J Clin Oncol. 2005 Nov 20; 23(33):8289-95.
Score: 0.011
-
Influence of allogeneic blood transfusion on clinical outcome during radiotherapy for cancer of the uterine cervix. Gynecol Obstet Invest. 2003; 56(1):28-34.
Score: 0.010
-
A comparison of four screening methods for cervical neoplasia in a developing country. Am J Obstet Gynecol. 2003 Feb; 188(2):395-400.
Score: 0.009
-
Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix. Gynecol Oncol. 2001 Jun; 81(3):424-32.
Score: 0.008
-
The National Cancer Data Base report on endometrial carcinoma in African-American women. Cancer. 1998 12 15; 83(12):2629-37.
Score: 0.007
-
Prognostic significance of human papillomavirus DNA in vulvar carcinoma. Obstet Gynecol. 1995 May; 85(5 Pt 1):709-15.
Score: 0.006
-
The effect of a full bladder on labor. Obstet Gynecol. 1983 Sep; 62(3):319-23.
Score: 0.002